PALISADE BIO, INC. (PALI) Total liabilities 2015–2025
PALISADE BIO, INC. (PALI) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2025 · since FY2015: $10.0M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.0M | +46.5% |
| FY2024 | $3.4M | +23.7% |
| FY2023 | $2.7M | -16.6% |
| FY2022 | $3.3M | — |
| FY2020 | $10.1M | +594.0% |
| FY2019 | $1.5M | -10.8% |
| FY2018 | $1.6M | -69.6% |
| FY2017 | $5.4M | -52.4% |
| FY2016 | $11.3M | +12.9% |
| FY2015 | $10.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice